PICKERING, ON, Dec. 9, 2024 /CNW/ - MTL Cannabis Corp. (CSE: MTLC) ("MTL" or the "Company") is pleased to announce details of its upcoming Annual General and Special Meeting (the "Meeting") and the availability of proxy-related materials.
MTL Cannabis Corp. logo (CNW Group/MTL Cannabis Corp.)
As stated in the news release of the Company dated November 22, 2024, the Meeting will be held on December 30, 2024, at 9:00am (Pacific Time), at Suite 2500, 700 West Georgia Street, Vancouver, BC, V7Y 1B3. Shareholders are encouraged to review and vote on the annual matters to be considered at the Meeting, which include:
to receive the audited financial statements of the Company for the fiscal year ended March 31, 2024, and the report of the auditors thereon;
to set the number of directors of the Company for the ensuing year at five (5) persons;
to elect directors of the Company; and
to confirm the appointment of MNP LLP as auditors of the Company and to authorize the board of directors to fix their renumeration.
For assistance or to request materials, shareholders may contact the Company at: Email: investors@mtlcannabis.ca Phone: 1-877-685-2266
Shareholder Voting Information
Shareholders can still vote their shares:
Registered Shareholders should receive emails providing a proxy with the voting control number and instructions for voting will be sent by the Company's transfer agent, Odyssey Trust Company, to registered shareholders. Registered shareholders who do not receive an email from Odyssey Trust Company with their proxy should contact Odyssey Trust Company at 1-888-290-1175 or email shareholder@odysseytrust.com to request their proxy and voting control number.
Beneficial Shareholders should contact their broker to request a voting information form, voting control number, and instructions for voting.
The Company encourages all shareholders to participate in the Meeting and to exercise their voting rights. Proxies must be submitted by 9:00am on December 24, 2024 (Pacific Time). Beneficial shareholders are advised to contact their intermediaries well in advance to ensure their voting instructions are processed and submitted before the deadline.
Withdrawal of By-Law Amendment
The Meeting is being held in accordance with and reliance on the Coordinated Blanket Order 51-931 - Temporary Exemption from requirements in National Instrument 51-102 Continuous Disclosure Requirements and National Instrument 54-101 Communication with Beneficial Owners of Securities of a Reporting Issuer to send certain proxy-related materials during a postal strike (the "Order").
As the original Proxy Materials included an ordinary resolution approving an adoption of new by-laws of the Company (the "By-Laws Amendment"), and such matters would not constitute an "annual matter" for the purposes of the Order, the Company has considered it expedient and in the best interests of the Company to withdraw the By-Laws Amendment matter from consideration at the Meeting. With the By-Laws Amendment being withdrawn, the Company has met all the conditions outlined in, and complied with the Order, and is relying on the exemption from the requirement to send certain proxy-related materials during a postal strike.
On Behalf of the Board of Directors,
"Michael Perron" Michael Perron Chief Executive Officer
About MTL Cannabis Corp.
MTL is the parent company of MTL Cannabis, a licensed producer operating from a 57,000 sq ft licensed indoor grow facility in Pointe Claire, Québec; Abba Medix Corp., a licensed producer in Pickering, Ontario that operates a leading medical cannabis marketplace; IsoCanMed Inc., a licensed producer in Louiseville, Québec growing best-in-class indoor cannabis, in its 64,000 sq. ft. production facility; and Canada House Clinics Inc., operating clinics across Canada that work directly with primary care teams to provide specialized cannabinoid therapy services to patients suffering from simple and complex medical conditions.
As a flower-first company built for the modern street, MTL Cannabis uses proprietary hydroponic growing methodologies supported by handcrafted techniques to produce products that are truly craft for the masses. MTL Cannabis focuses on craft quality cannabis products, including lines of dried flower, pre-rolls and hash marketed under the "MTL Cannabis", "Low Key by MTL" and "R'belle" brands for the Canadian market through nine distribution arrangements with various provincial cannabis distributors. MTL Cannabis has also developed several export channels for bulk and unbranded GACP quality cannabis.
It is MTL's goal for Abba Medix Corp. to become the leading distributor of medical cannabis in Canada and for Canada House Clinics to be the leading Canadian provider of medical cannabis clinic services.
Cautionary Statement Regarding Forward-Looking Information. This press release contains forward- looking statements, including statements that relate to, among other things, the Company's clinic, production and technology businesses, its future plans, the Company's markets, objectives, goals, strategies, intentions, beliefs, expectations and estimates, and can generally be identified by the use of words such as "may", "will", "could", "should", "would", "likely", "possible", "expect", "intend", "estimate", "anticipate", "believe", "plan", "objective" and "continue" (or the negative thereof) and words and expressions of similar import. Although the Company believes that the expectations reflected in such forward-looking statements are reasonable, such statements involve risks and uncertainties, and undue reliance should not be placed on such statements. Certain material factors or assumptions are applied in making forward-looking statements, and actual results may differ materially from those expressed or implied in such statements. Material assumptions used to develop forward-looking information in this news release include, the regulations related to cannabis use under the Cannabis Act (Canada); Company liquidity and capital resources, including the availability of additional capital resources to fund its activities and repay its outstanding indebtedness; level of competition; the ability to adapt products and services to the changing market; the ability to attract and retain key executives; the ability to execute strategic plans; continued integration of business unit, expansion activities at all our operating locations; and the leveraging of cash flow from operations to accelerate growth and further improve the Company's balance sheet. Additional information about material factors that could cause actual results to differ materially from expectations and about material factors or assumptions applied in making forward-looking statements may be found in the Company's Listing Statement dated August 14, 2023 and its most recent annual and interim Management's Discussion and Analysis under "Risk and Uncertainties" as well as in other public disclosure documents filed with Canadian securities regulatory authorities. The Company does not undertake any obligation to update publicly or to revise any of the forward-looking statements contained in this document, whether as a result of new information, future events or otherwise, except as required by law.
Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.
